Get started
Addex Therapeutics LtdAddex Therapeutics LtdAddex Therapeutics Ltd

Addex Therapeutics Ltd

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsForecastSeasonalsETFs

APE chart


Full chart

Key stats


Market capitalization
‪13.28 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
1.1590
Basic EPS (TTM)
0.0920 EUR
Net income (FY)
‪7.50 M‬ EUR
Revenue (FY)
‪436.13 K‬ EUR
Shares float
‪89.68 M‬
Beta (1Y)
0.39

Employees


Employees (FY)
2
Change (1Y)
−21 −91.30%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Addex Therapeutics Ltd


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Timothy Dyer
Website
addextherapeutics.com
Headquarters
Geneva
Founded
2002
ISIN
CH0029850754
FIGI
BBG000QVQ2N4
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Check out other big names from the same industry as APE.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

APE news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Addex Therapeutics Ltd stocks are traded under the ticker APE.
APE reached its all-time high on Jul 19, 2007 with the price of 42.2800 EUR, and its all-time low was 0.0030 EUR and was reached on May 6, 2025. View more price dynamics on APE chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Addex Therapeutics Ltd financials in yearly and quarterly reports right on TradingView.
APE net income for the last quarter is ‪−1.54 M‬ EUR, while the quarter before that showed ‪−1.28 M‬ EUR of net income which accounts for −19.92% change. Track more Addex Therapeutics Ltd financial stats to get the full picture.
No, APE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 25, 2025, the company has 2 employees. See our rating of the largest employees — is Addex Therapeutics Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Addex Therapeutics Ltd EBITDA is ‪−2.49 M‬ EUR, and current EBITDA margin is −608.50%. See more stats in Addex Therapeutics Ltd financial statements.
Like other stocks, APE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Addex Therapeutics Ltd stock right from TradingView charts — choose your broker and connect to your account.